This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent. Top assignee: Aktis Oncology, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovations of James M. Way
Introduction
James M. Way is an accomplished inventor based in Raleigh, NC (US). He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic agents. His work focuses on innovative solutions for diagnosing and treating diseases.
Latest Patents
James M. Way holds a patent for "Nectin-4 binding miniproteins, conjugates and uses thereof." This patent includes polypeptides and conjugates, such as radionuclide conjugates, which are useful in compositions and methods for treating, diagnosing, monitoring, and imaging diseases associated with the expression of Nectin-4.
Career Highlights
Way is currently employed at Aktis Oncology, Inc., where he continues to advance his research and development efforts. His work is pivotal in creating new therapeutic options for patients suffering from various conditions.
Collaborations
James M. Way collaborates with notable colleagues, including William C. Blackwell, III and Michael Lawrence Doligalski. These partnerships enhance the innovative potential of his projects and contribute to the advancement of medical science.
Conclusion
James M. Way's contributions to biotechnology and his innovative patent work exemplify the impact of dedicated inventors in the medical field. His ongoing efforts at Aktis Oncology, Inc. continue to pave the way for new treatments and diagnostic methods.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile